32
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Use of laser microdissection in the analysis of renal-infiltrating T cells in MRL/lpr mice

, , , , , , , , & show all
Pages 385-393 | Received 25 Jan 2008, Accepted 12 Mar 2008, Published online: 02 Jan 2014

References

  • Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, WilsonCB, McConahey PJ, et al. Spontaneous murine lupus-like syndromes.Clinical and immunopathological manifestations inseveral strains. J Exp Med. 1978;148:1198�215.
  • Furukawa F, Yoshimasu T. Animal models of spontaneous anddrug-induced cutaneous lupus erythematosus. Autoimmun Rev.2005;4:345�50.
  • Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA,Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature.1992;356:314�7.
  • Murray L, Martens C. Abnormal T cells from lpr mice downregulatetranscription of interferon-gamma and tumor necrosisfactor-alpha in vitro. Cell Immunol. 1990;126:367�76.
  • Koh DR, Ho A, Rahemtulla A, Fung-Leung WP, Griesser H, MakTW. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells.Eur J Immunol. 1995;25: 2558�62.
  • Peng SL, Madaio MP, Hughes DP, Crispe IN, Owen MJ, Wen L,et al. Murine lupus in the absence of alpha beta T cells.J Immunol. 1996;156:4041�9.
  • Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R,Kobayakawa T, et al. Imbalance towards Th1 predominance isassociated with acceleration of lupus-like autoimmune syndromein MRL mice. J Clin Invest. 1996;97: 1597�604.
  • Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY. The role ofinterleukin 12 and nitric oxide in the development of spontaneousautoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med.1996;183: 1447�59.
  • Schorlemmer HU, Dickneite G, Kanzy EJ, Enssle KH. Modulationof the immunoglobulin dysregulation in GvH- and SLE-likediseases by the murine IL-4 receptor (IL-4-R). Inflamm Res.1995;44:s194�6.
  • Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest. 1997;99: 1936–46.
  • Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, et al. Interleukin 13 induces interleukin 4-indepen-dent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA. 1993;90:3730–4.
  • Spadaro A, Rinaldi T, Riccieri V, Taccari E, Valesini G. Inter-leukin-13 in autoimmune rheumatic diseases: relationship with autoantibody profile. Clin Exp Rheumatol. 2002;20: 213–6.
  • Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–41.
  • Bi Y, Liu G, Yang R. 'Th17 cell induction and immune regulatory effects. J Cell Physiol. 2007;211: 273–8.
  • Nose M, Nishimura M, Ito MR, Toh J, Shibata T, Sugisaki T. Arteritis in a novel congenic strain of mice derived from MRL/ Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production. Am J Pathol. 1996;149:1763–9.
  • Pinzani P, Orlando C, Pazzagli M. Laser-assisted microdissection for real-time PCR sample preparation. Mol Aspects Med. 2006;27:140–59.
  • Ladanyi A, Sipos F, Szoke D, Galamb 0, Molnar B, Tulassay Z. Laser microdissection in translational and clinical research. Cytometry A. 2006;69:947–60.
  • Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. IFN-gamma receptor signaling is essential for the initiation, acceler-ation, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol. 1998;161:494–503.
  • Haas C, Ryffel B, Le Hir M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol. 1997;158:5484–91.
  • Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest. 1998;101:364–71.
  • Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoan-tibodies and lupus nephritis in transgenic mice expressing interferon-gamma in the epidermis. J Exp Med. 1997;186:1451–9.
  • Seery JP. IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus? Arthritis Res. 2000;2:437-40.
  • Morimoto S, Tokano Y, Kaneko H, Nozawa K, Amano H, Hashimota H. The increased interleukin-13 in patients with sys-temic lupus erythematosus: relations to other Thl-, 'Th2-related cytokines and clinical findings. Autoimmunity. 2001;34:19–25.
  • Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, et al. Membranous glomerulonephritis development with 'Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol. 2005;175:7185–92.
  • Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19: 683–765.
  • Beebe AM, Cua DJ, de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 2002;13: 403–12.
  • Csiszar A, Nagy G, Gergely P, Pozsonyi T, Pocsik E. Increased interferon-gamma (IFN-y), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 2000;122: 464–70.
  • Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in sys-temic lupus erythematosus reflect disease activity. Lupus. 1995;4:393–5.
  • Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, et al. IL-10 regulates murine lupus. J Immunol. 2002;169:2148–55.
  • Beissert S, Schwarz A, Schwarz T. Regulatory T cells. J Invest Dermatol. 2006;126:15–24.
  • van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeder FP, Taams LS. CD4 + CD25 + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50: 2775–85.
  • Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003;21:273–6.
  • Hocke AC, Ermert M, Althoff A, Brell B, N'Guessan PD, Suttorp N, et al. Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans. Cytokine. 2006;33: 199–211.
  • Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1–8.
  • Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003;14:155–74.
  • Kolls JK, Linden A. Interleukin-17 family members and inflam-mation. Immunity. 2004;21:467–76.
  • Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflam-matory cytokine (IL-18, IL-17, IL-12) and 'Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9:589–93.
  • Dong G, Ye R, Shi W, Liu S, Wang T, Yang X, et al. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J. 2003;116:543–8.
  • Cai P, König R, Khan MF, Qiu S, Kaphalia BS, Ansari GA. Autoimmune response in MRL+/+ mice following treatment with dichloroacetyl chloride or dichloroacetic anhydride. Toxicol Appl Pharmacol. 2006;216:248–55.
  • Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007;21:2931–8.
  • Maeda K, Lee DS, Yanagimoto Ueta Y, Suzuki H. Expression of uterine sensitization-associated gene-1 (USAG-1) in the mouse uterus during the pen-implantation period. J Reprod Dev. 2007;53:931–6.
  • Khodosevich K, Inta D, Seeburg PH, Monyer H. Gene expression analysis of in vivo fluorescent cells. PLoS ONE. 2007;2:e1151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.